High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$59.3M
$59,303,378
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| GILD |
GILEAD SCIENCES, INC.
|
CEO
10b5-1 Sell
|
2026-02-27 | $1,447,859Largex3 | S | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
CFO
10b5-1 Sell
|
2026-02-17 | $463,290 | S | Form 4 |
|
GILD
M
GILEAD SCIENCES, INC.
Mercier Johanna
• Officer • Chief Comm & Corp Aff Officer
Other
2026-02-17
$1,666,000Large
|
||||||
| GILD |
GILEAD SCIENCES, INC.
|
Officer • Chief Comm & Corp Aff Officer
Other
|
2026-02-17 | $1,666,000Large | M | Form 4 |
|
GILD
S
GILEAD SCIENCES, INC.
Mercier Johanna
• Officer • Chief Comm & Corp Aff Officer
10b5-1 Sell
2026-02-17
$4,324,228Largex3
|
||||||
| GILD |
GILEAD SCIENCES, INC.
|
Officer • Chief Comm & Corp Aff Officer
10b5-1 Sell
|
2026-02-17 | $4,324,228Largex3 | S | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
CEO
Other
|
2026-02-05 | $7,633,396Whale | M | Form 4 |
|
GILD
S
GILEAD SCIENCES, INC.
O'Day Daniel Patrick
• CEO
10b5-1 SellΔOwn -15.8%
2026-02-05
$17,346,000MEGA
|
||||||
| GILD |
GILEAD SCIENCES, INC.
|
CEO
10b5-1 SellΔOwn -15.8%
|
2026-02-05 | $17,346,000MEGA | S | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
CEO
10b5-1 Sell
|
2026-01-28 | $1,398,911Largex2 | S | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
CEO
Other
|
2026-01-23 | $7,633,396Whale | M | Form 4 |
|
GILD
S
GILEAD SCIENCES, INC.
O'Day Daniel Patrick
• CEO
10b5-1 SellΔOwn -16.9%
2026-01-23
$15,611,400MEGA
|
||||||
| GILD |
GILEAD SCIENCES, INC.
|
CEO
10b5-1 SellΔOwn -16.9%
|
2026-01-23 | $15,611,400MEGA | S | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
Director
Other
|
2026-01-20 | $337,250 | M | Form 4 |
|
GILD
S
GILEAD SCIENCES, INC.
Bluestone Jeffrey
• Director
10b5-1 SellΔOwn -35.9%
2026-01-20
$617,500
|
||||||
| GILD |
GILEAD SCIENCES, INC.
|
Director
10b5-1 SellΔOwn -35.9%
|
2026-01-20 | $617,500 | S | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
CFO
10b5-1 Sell
|
2026-01-15 | $372,930 | S | Form 4 |
|
GILD
S
GILEAD SCIENCES, INC.
Mercier Johanna
• Officer • Chief Commercial Officer
10b5-1 Sell
2026-01-15
$372,930
|
||||||
| GILD |
GILEAD SCIENCES, INC.
|
Officer • Chief Commercial Officer
10b5-1 Sell
|
2026-01-15 | $372,930 | S | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
CFO
10b5-1 Sell
|
2025-12-15 | $366,000 | S | Form 4 |
|
GILD
S
GILEAD SCIENCES, INC.
Mercier Johanna
• Officer • Chief Commercial Officer
10b5-1 Sell
2025-12-15
$366,000
|
||||||
| GILD |
GILEAD SCIENCES, INC.
|
Officer • Chief Commercial Officer
10b5-1 Sell
|
2025-12-15 | $366,000 | S | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
CFO
Equity Compensation
|
2025-12-10 | $0 | M | Form 4 |
|
GILD
M
GILEAD SCIENCES, INC.
Mercier Johanna
• Officer • Chief Commercial Officer
Equity Compensation
2025-12-10
$0
|
||||||
| GILD |
GILEAD SCIENCES, INC.
|
Officer • Chief Commercial Officer
Equity Compensation
|
2025-12-10 | $0 | M | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
CEO
Equity Compensation
|
2025-12-10 | $0 | M | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
Director
Equity Compensation
|
2025-11-28 | $324,600x2 | M | Form 4 |
|
GILD
S
GILEAD SCIENCES, INC.
Bluestone Jeffrey
• Director
Discretionary SellΔOwn -35.9%
2025-11-28
$625,400
|
||||||
| GILD |
GILEAD SCIENCES, INC.
|
Director
Discretionary SellΔOwn -35.9%
|
2025-11-28 | $625,400 | S | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
Director
Equity Compensation
|
2025-11-28 | $227,205x2 | M | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
Director
10b5-1 SellΔOwn -67.7%
|
2025-11-28 | $356,516 | S | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
CEO
10b5-1 Sell
|
2025-11-28 | $1,265,444Largex2 | S | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
Director
Equity Compensation
|
2025-11-26 | $227,286x2 | M | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
Director
10b5-1 SellΔOwn -67.7%
|
2025-11-26 | $356,671 | S | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
CFO
10b5-1 Sell
|
2025-11-17 | $313,075 | S | Form 4 |
|
GILD
M
GILEAD SCIENCES, INC.
Mercier Johanna
• Officer • Chief Commercial Officer
Other
2025-11-17
$1,666,000Large
|
||||||
| GILD |
GILEAD SCIENCES, INC.
|
Officer • Chief Commercial Officer
Other
|
2025-11-17 | $1,666,000Large | M | Form 4 |
|
GILD
S
GILEAD SCIENCES, INC.
Mercier Johanna
• Officer • Chief Commercial Officer
10b5-1 Sell
2025-11-17
$3,524,173Largex2
|
||||||
| GILD |
GILEAD SCIENCES, INC.
|
Officer • Chief Commercial Officer
10b5-1 Sell
|
2025-11-17 | $3,524,173Largex2 | S | Form 4 |
|
GILD
M
GILEAD SCIENCES, INC.
Telman Deborah H
• Officer • EVP, Corporate Affairs & GC
Other
2025-11-12
$3,505,885Largex3
|
||||||
| GILD |
GILEAD SCIENCES, INC.
|
Officer • EVP, Corporate Affairs & GC
Other
|
2025-11-12 | $3,505,885Largex3 | M | Form 4 |
|
GILD
S
GILEAD SCIENCES, INC.
Telman Deborah H
• Officer • EVP, Corporate Affairs & GC
10b5-1 Sell
2025-11-12
$6,590,487Whalex3
|
||||||
| GILD |
GILEAD SCIENCES, INC.
|
Officer • EVP, Corporate Affairs & GC
10b5-1 Sell
|
2025-11-12 | $6,590,487Whalex3 | S | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
CEO
10b5-1 Sell
|
2025-10-28 | $1,193,926Largex2 | S | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
CFO
10b5-1 Sell
|
2025-10-15 | $295,200 | S | Form 4 |
|
GILD
S
GILEAD SCIENCES, INC.
Mercier Johanna
• Officer • Chief Commercial Officer
10b5-1 Sell
2025-10-15
$354,240
|
||||||
| GILD |
GILEAD SCIENCES, INC.
|
Officer • Chief Commercial Officer
10b5-1 Sell
|
2025-10-15 | $354,240 | S | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
CEO
10b5-1 Sell
|
2025-09-29 | $1,116,564Largex2 | S | Form 4 |
| GILD |
GILEAD SCIENCES, INC.
|
CFO
10b5-1 Sell
|
2025-09-15 | $283,925 | S | Form 4 |
|
GILD
S
GILEAD SCIENCES, INC.
Mercier Johanna
• Officer • Chief Commercial Officer
10b5-1 Sell
2025-09-15
$340,710
|
||||||
| GILD |
GILEAD SCIENCES, INC.
|
Officer • Chief Commercial Officer
10b5-1 Sell
|
2025-09-15 | $340,710 | S | Form 4 |